DuPont gets Gates grant for protein drug production platform

By Gareth Macdonald contact

- Last updated on GMT

iStock/markusblanke
iStock/markusblanke

Related tags: Bill & melinda gates foundation

DuPont has joined a Gates Foundation backed effort to develop low cost production methods for therapeutic proteins.

The Bill & Melinda Gates Foundation awarded the firm’s DuPont Industrial Biosciences division a grant to support development of production systems for protein-based medicines, with a particular focus on scalable manufacturing platforms.

Division president William F. Feehery said: “We cannot underestimate the complexity of this challenge. At the same time, we cannot turn our backs on the possibility of improving access and affordability of life-saving medications for communities around the world.

This is cutting-edge science. We are honoured to work with a leading organization like The Gates Foundation to tackle this type of issue, as no one company or entity can get there on their own​.”

DuPont is one of a number of companies the Gates Foundation has tasked with lowering the cost of making large molecule drugs.

Last week, the Foundation granted Belgian technology firm Univercells - and consortium partners Batavia Biosciences and Natrix Separations - $12m (€12.5m) to develop a vaccine production platform.

DuPont is due to merge with Dow Chemical under a deal announced in late 2015​.

Previously the aim was to complete the merger by the end of this year. However, in October the firms said completion would likely be delayed until early 2017​.

Related products

show more

Protecting Protein, Protecting the Industry

Protecting Protein, Protecting the Industry

European Specialist Sports Nutrition Alliance | 17-Jul-2018 | Technical / White Paper

Protein spiking, or adulteration, is an emerging issue in Europe. ESSNA knows that as a result of some uncertainty around the regulatory definition of...

ESSNA’s ABC’s of Sports Nutrition

ESSNA’s ABC’s of Sports Nutrition

European Specialist Sports Nutrition Alliance | 13-Jun-2018 | Technical / White Paper

To combat the raft of misconceptions around the sports nutrition world, ESSNA has produced its ultimate guide to the industry, covering everything from...

Innovate in Joint Health with b-2Cool®

Innovate in Joint Health with b-2Cool®

BIOIBERICA, S.A. | 11-Jun-2018 | Data Sheet

b-2Cool® is a natural ingredient supplying native (undenatured) type II collagen.

b-2Cool® is manufactured through a strictly controlled...

Customized Fill Release in Gelatine Soft Capsules

Customized Fill Release in Gelatine Soft Capsules

Gelita AG | 21-May-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars